Investigational Product Accountability: End-to-End Controls at the Site
Investigational Product Accountability: End-to-End Controls at the Site In the domain of clinical research, the integrity and accountability of Investigational Products (IPs) are paramount. Both regulatory authorities and clinical operations professionals strive to ensure that IPs are managed in a manner that maximizes safety and efficacy. This article will delve into the crucial aspects of…
Read More “Investigational Product Accountability: End-to-End Controls at the Site” »